B-Secur is a leader in advanced ECG signal processing and analytics, developing FDA-cleared software that powers next-generation wearable and medical devices. Our mission is to help save and improve lives by enabling accurate, real-world heart health insights across a broad range of products and environments.
Our flagship technology, HeartKey®, provides high-accuracy ECG interpretation for continuous or spot-check heart rate monitoring and supports multiple arrhythmia detections, including atrial fibrillation, bradycardia and tachycardia. Device agnostic, HeartKey® integrates into consumer wearables and clinical systems such as smartwatches, fitness bands and ambulatory cardiac monitors. It supports both embedded and cloud implementations, enabling deployment across low-power devices and connected health platforms.
Through ABEL Labs, our in-house biosensing research and validation facility, we explore the fusion of ECG with emerging sensing modalities such as bio-impedance, advancing the future of connected health innovation.
Beyond software analytics, B-Secur provides expertise in electrode design, hardware design, system validation and regulatory support, including FDA 510(k) preparation and ISO 13485 quality management.
Trusted by global technology leaders, we accelerate development, de-risk integration and help partners bring high-performance, medical-grade devices to market with confidence.
